-
Abstract Number: PB1040
A 3D in vitro Model of Inflammation-associated Bleeding
-
Abstract Number: PB0784
A 5-Year Study of Arterial and Venous Thromboses in Greek Infants, Children and Adolescents. Comparison of Data Before and during the Pandemic Period
-
Abstract Number: PB0624
A Bleed Suppression Efficacy of Emicizumab in Patients with Hemophilia A whose Therapies Switched from Conventional Prophylaxis
-
Abstract Number: OC 48.1
A Blood Coagulation Factor IX Variant that Functions Independently of Factor VIII Mitigates the Hemophilia A Phenotype in Patient Plasma
-
Abstract Number: PB0807
A Case of a Pediatric Patient with Protein S Heerlen Polymorphism and Deep Venous Thrombosis
-
Abstract Number: PB0408
A Case of Congenital Afibrinogenemia with Two Successful Spontaneous Delivery After Recurrent Pregnancy Losses
-
Abstract Number: PO117
A Case of Recurrent Myocardial Infarction and Heterozygous Factor V Leiden
-
Abstract Number: PB0812
A Case Report and Comprehensive Review of Acquired Purpura Fulminans in Children
-
Abstract Number: PB1072
A Comparative Cohort Study of Serum Rivaroxaban Levels in Singaporean (SG) and British (UK) Non-valvular Atrial Fibrillation (NVAF) Patients
-
Abstract Number: PB0080
A Comparative Study of SEER Sonorheometry versus Thromboelastography during Cardiac Surgery with Cardiopulmonary Bypass
-
Abstract Number: PB0984
A comparison of Five Platelet Reactivity Tests in Over 3,000 Participants of the Framingham Heart Study
-
Abstract Number: PB0364
A Comparison of Functional Methods with Absolute Quantification of Heparin Levels in Clinical Samples by Heparin Red Assay
-
Abstract Number: PB1073
A Comparison of the Incidence of Traumatic Brain Injury in Anticoagulated and Non-anticoagulated Head Injured Patients
-
Abstract Number: PB0810
A Comprehensive Review of Tumour Thrombus in Pediatric Wilms Tumour Patients
-
Abstract Number: PB0781
A Conservative Therapy Spontaneous Intracranial Hemorrhage in a Pediatric Patient with Severe Acquired Aplastic Anemia
-
Abstract Number: PB0003
A Coupled 1D-3D Hybrid Model for Patient-specific Coronary Flow Simulations: Bridging the Gap between Macroscale Hemodynamics and Microscale Thrombosis Models
-
Abstract Number: PB1057
A Diagnostic Solution for Lupus Anticoagulant Testing in Patients Taking Direct Oral FXa Inhibitors Using DOAC Filter
-
Abstract Number: OC 74.2
A Heterozygous Mutation in SLFN14 Influences Species-specific Haematopoietic Regulation in Platelet and Erythroid Lineages
-
Abstract Number: PB0002
A Machine-learning-Based Bio-psycho-Social Model for the Prediction of Non-obstructive and Obstructive Coronary Artery Disease
-
Abstract Number: PB1287
A Major Knowledge Gap in Women’s Health: The Combined Effect of Antifibrinolytics and Estrogen on Risk of Thromboembolism – A Scoping Review
-
Abstract Number: OC 35.4
A Major Reservoir for Heparin-releasable TFPIα is Extracellular Matrix
-
Abstract Number: OC 54.1
A Mechanism for Hereditary Angioedema Caused by a plasminogen Lys311Glu Substitution
-
Abstract Number: OC 16.4
A Mouse Model of Protease Activated Receptor 4 (PAR4) variant rs2227376 Has Reduced Platelet Reactivity to Physiological Doses of Thrombin
-
Abstract Number: PB1230
A Multi-disciplinary Approach to Improving Temporary IVC Filter Retrieval Rates
-
Abstract Number: PB0821
A Multicenter Double-blind, Double-dummy, Randomized Study of rhTPO vs Eltrombopag in the Treatment of Chinese Immune Thrombocytopenia
-
Abstract Number: PB0857
A Multicenter Retrospective Evaluation of Direct Oral Anticoagulants for the Treatment of Heparin Induced Thrombocytopenia
-
Abstract Number: LPB0130
A Multiscale Framework for Patient-specific Predictions of Thrombus Growth
-
Abstract Number: PB1286
A New Pharmacodynamic Test to Evaluate Effects of Oral Contraceptives on Coagulation
-
Abstract Number: PB0904
A Novel Disease-causing Variant in the GP1BA Gene Related to Bernard Soulier Syndrome
-
Abstract Number: PB0880
A Novel Dual AntiPlatelet and AntiCoagulant APAC: Interaction Between Platelet Factor 4 (PF4) and APAC Decreases Functional Activity
-
Abstract Number: PB1055
A Novel ELISA Assay for the Detection of Anti-prothrombin Antibodies in APS Patients at High Risk of Thrombosis
-
Abstract Number: PB0896
A Novel Hemizygous Variant in GATA1 Associated with Bleeding Diathesis and Platelet Dysfunction in Two Unrelated Patients
-
Abstract Number: PB0029
A Novel Mouse Model for Cerebral Venous Thrombosis
-
Abstract Number: PB0342
A Novel Paper-based Test for Diagnostic of Fibrinogen Levels on Whole Blood
-
Abstract Number: OC 61.3
A Novel Particle-based Model Delivers Mechanistic Insights into Arterial Thrombus Heterogeneity
-
Abstract Number: OC 05.3
A Novel Prediction Platform to Enhance the Design of Therapeutic SERPINs
-
Abstract Number: PB0650
A Novel Strategy for Platelet-specific Gene Therapy for the Treatment of Hemophilia A via Intranasal Delivery Lentiviral Vectors Containing Factor VIII
-
Abstract Number: PB0971
A Novel Therapeutic Strategy for Hepatocellular Carcinoma Based on the Tumor-platelet Interaction
-
Abstract Number: PB0402
A Patient with Congenital Hypofibrinogenemia who Showed Embryo Implantation, Continuation of Pregnancy, and Delivery Following Continuous Transfusion of Dry Human Fibrinogen Preparations
-
Abstract Number: PB1121
A Population-Based Descriptive Study of Long-term Anticoagulation in the Treatment and Secondary Prophylaxis of Venous Thromboembolism in Men with Prostate Cancer in Sweden
-
Abstract Number: PB1155
A Potential Risk of Venous Thrombosis Induced by Nanomaterials and the Protection Role of Nrf2
-
Abstract Number: PB1068
A Prolonged Actived Partial Thromboplastin Time Revealing a Childhood Systemic Lupus erythematosus
-
Abstract Number: PB0640
A Prospective Cohort Study on Disabilities in Patients with Haemophilia Using Orthopaedic Scores
-
Abstract Number: PB0450
A Prospective Comparison Study of the Diagnosis of Disseminated Intravascular Coagulation (DIC) Comparing Between ISTH DIC Scoring system and General Practice in Prediction of 28-day Mortality
-
Abstract Number: PB0806
A Prospective Data Collection Utilizing the International Pediatric Thrombosis Network (IPTN) to Understand the Epidemiology for the Development of Neonatal Renal Vein Thrombosis
-
Abstract Number: PB0863
A Puzzling HIT History: HIT Associated with Fondaparinux or True Autoimmune HIT?
-
Abstract Number: PB0586
A Qualitative Study on the Experiences of Hemophilia Carriers before, during and after Pregnancy
-
Abstract Number: PB0933
A Quantitative Evaluation of vWF Multimeric Structure in Patients with Different Types of vWD and aVWS
-
Abstract Number: OC 60.1
A Randomized, Double-blind, Placebo-controlled, Phase 2 Study Evaluating Safety and Efficacy of AB023 in Hemodialysis Patients
-
Abstract Number: PO165
A Rare Case of Bi-atrial Thrombi in a Stage IV Pancreatic Cancer Patient with Atrial Fibrillation on Warfarin
-
Abstract Number: PB0801
A Rare Case of Thrombotic Storm in Henoch-Schonlein Purpura
-
Abstract Number: PB0005
A Rare Presentation of ST-segment Elevation Myocardial Infarction Associated with Ovarian Stimulation in the Absence of Ovarian Hyperstimulation Syndrome
-
Abstract Number: PB1256
A Real-world Experience of Venous Thromboembolism (VTE) Management in Australia
-
Abstract Number: PB1272
A Realist Evaluation on Therapeutic Elastic Compression Therapy Pathways for DVT- and CVD Patients to Develop Evidence-informed Improvement Strategies
-
Abstract Number: PO156
A Refractory Thrombotic Thrombocytopenic Purpura Case Complicated by Hepatic Sinusoidal Obstruction Syndrome and Successful Management with Defibrotide
-
Abstract Number: PB1249
A Retrospective Evaluation of the Management of Isolated Distal Deep Vein Thrombosis in Australia
-
Abstract Number: PB0776
A Retrospective Review of Diagnosis and Management of Heavy Menstrual Bleeding and Co-morbidities in Patients Seen in Young Women’s Blood Clinic
-
Abstract Number: PB0491
A Review Following Implemented Training for Health Care Practitioners in Primary Care Settings of Immunisation Practice in Children with Bleeding Disorders
-
Abstract Number: PB0703
A Review of Beighton Scores Recorded for All Patients with a Bleeding Tendency Registered at One Haemophilia Centre without Another Formal Bleeding Disorder Diagnosis
-
Abstract Number: PB0751
A Role of Possible Synergistic Effect of P Selectin Glycoprotein Ligand 1 Polymorphism and Antiphosholipid Antibodies on Thrombosis in Myeloproliferative Neoplasia Patients
-
Abstract Number: PB1025
A rRle for the JAK/STAT5 Axis in GPVI-mediated Platelet Function
-
Abstract Number: PB0663
A Savvy Approach to Clinical Trial Recruitment for the SAAVY (Seroprevalence of AAV AntibodY) Study in the Era of COVID-19: Designing for a Prospective, Observational Study in the United States during a Global Pandemic
-
Abstract Number: PB0321
A Service Evaluation of Prothrombin Complex Concentrate Use and Safe Administration Procedures in a Tertiary Hospital and Trauma Centre
-
Abstract Number: LPB0098
A Simple Score to Evaluate Bleeding Risk in Medical Patients Taking Antiplatelets for Cardiovascular Prevention
-
Abstract Number: PB1182
A Simplified Decision Rule to Rule out Deep Vein Thrombosis Using Clinical Assessment and D-dimer
-
Abstract Number: PB0533
A single center study of bone mineral density in adult patients with severe Haemophilia A and correlation with markers of bone metabolism
-
Abstract Number: OC 14.2
A Single-domain Antibody Anti-protein Z Dependent Protease Inhibitor Improves Thrombin Generation in Hemophilia
-
Abstract Number: LB 01.3
A Six-week versus Three-month Duration of Anticoagulation for Acute Provoked Venous Thromboembolism in Patients < 21 Years Old: Results of the Multinational Kids-DOTT Randomized Controlled Trial
-
Abstract Number: PB0628
A Study of Psychosocial Issues for Mothers of Children with Hemophilia
-
Abstract Number: PB1270
A Survey of Current Anticoagulation Patient Education Practices and Development
-
Abstract Number: PB0367
A Systematic Review and Meta-analysis of Performances of Prototype and Commercial DOAC Dipstick Tests for Detecting Direct Oral Anticoagulants in Patient Urine Samples – Increasing Confidence for Testing in Emergency Care
-
Abstract Number: PB1223
A Systematic Review and Meta-analysis on the Use of Chemoprophylaxis in the Prevention of Venous Thromboembolism in Colorectal Cancer Surgery in Asian Population
-
Abstract Number: PB0682
A Systematic Review on the Pharmacokinetics and Associated Pharmacodynamics of Emicizumab in Humans
-
Abstract Number: OC 47.2
A Thrombospondin-1 Release Assay (TRA) Coupled to PF4-treated Frozen Platelets is Highly Accurate for the Detection of Pathogenic HIT Antibodies: Implications for Development of a Near-patient HIT in vitro Diagnostic Assay
-
Abstract Number: OC 27.4
A Unique Loop Structure in the A2-domain of Pseudonaja textilis Factor Va Prevents Activated Protein C-catalyzed A2-domain Dissociation
-
Abstract Number: PB0186
A Weight-based Approach to Thromboprophylaxis Dosing for Medical Inpatients with COVID-19
-
Abstract Number: OC 75.4
AAV Delivery of a Novel Human Factor VIII Variant with Improved Secretion Results in Higher FVIII Expression in Hemophilia A Dogs
-
Abstract Number: OC 69.3
Abdominal Thromboses in Pediatric Patients: What Do we Know?
-
Abstract Number: LB 01.2
Abelacimab for Prevention of Venous Thromboembolism
-
Abstract Number: PB0954
Aberrant Expression of Lnc-MEG3 and Lnc-NOTCH1 Predicts Refractory Phenotype in Chronic Idiopathic Thrombocytopenic Purpura
-
Abstract Number: PB0095
Ability of Fibrin Monomers and Fibrinogen Levels to Predict In-hospital Mortality in Patients with Severe Trauma
-
Abstract Number: PB1153
Abnormal Thrombin Generation in Children with Thrombosis
-
Abstract Number: PB1141
ABO Blood Groups as a Risk Factor for the Development of Deep Vein Thrombosis of the Lower Extremities in Elderly and Senile Patients
-
Abstract Number: LPB0099
Absence of CCR5/CCL5 Axis Inhibits Thrombus Resolution through Reduced uPA, tPA and VEGF Expressions in DVT Model
-
Abstract Number: PB0032
Absolute Measurement of Bovine and Porcine Heparin Red Assay Utilizing the Heparin Red Assay. Applications in the Study of Pharmacokinetics and Pharmacodynamics
-
Abstract Number: PB1081
Accounting of Symptoms and Ejection Fraction May Improve Prediction of Left Atrial Thrombus in Patients with Non-valvular Atrial Fibrillation before Catheter Ablation or Cardioversion
-
Abstract Number: PB0190
ACE2, ACE and Thromboinflammation in COVID-19
-
Abstract Number: PB1026
Acetyl-CoA Carboxylase Inhibition Alters Tubulin Acetylation and Aggregation in Thrombin-stimulated Platelets
-
Abstract Number: PB0442
Acquired Haemophilia A – Data from a Regional Blood Center in Rio de Janeiro, Brazil
-
Abstract Number: PB0447
Acquired Hemophilia A – Misdiagnosis and Possible Hazards: A Case Report
-
Abstract Number: PB0449
Acquired Hemophilia A as a Complication of Multiple Myeloma
-
Abstract Number: PB0443
Acquired Hemophilia A Presenting as Spontaneous Intramuscular Hematomas
-
Abstract Number: PB0448
Acquired Hemophilia A: Pediatric Case Report
-
Abstract Number: PB0446
Acquired Hemophilia after Chemotherapy: Oxaliplatin and Capecitabine, a Case Report
-
Abstract Number: PB0739
Acquired Isolated FVII Deficiency in Oncological Patients
-
Abstract Number: OC 01.4
Acquired Platelet GPVI Signaling Deficiency Occurs Early in Patients with Gram-Positive or Gram-negative Sepsis
-
Abstract Number: PB0952
Acquired von Willebrand Disease
-
Abstract Number: PB0804
Acquired von Willebrand Disease in a Child as Leading Symptom of Systemic Lupus Erythematosus
-
Abstract Number: OC 40.2
Acquired von Willebrand Disease in Pediatric Patients Undergoing ECMO Support
-
Abstract Number: PB0938
Acquired von Willebrand Disease: The Diagnosis and Management of an Underdiagnosed Coagulopathy
-
Abstract Number: PB0888
Acquired δ-Storage Pool Disorder Co-existing with Acquired Factor V Deficiency in Myelodysplastic Syndrome / Myeloproliferative Neoplasm
-
Abstract Number: LPB0051
ACTIMIS Trial: Safety Interim Analysis Data of Glenzocimab, a Novel Antiplatelet Agent on Top of Acute Ischemic Stroke Standard of Care
-
Abstract Number: PB0356
Activated charcoal can be used as an effective in vitro removal agent of direct oral anticoagulants dabigatran, rivaroxaban and apixaban in plasma of patients with protein S activity testing
-
Abstract Number: PB1161
Activated Charcoal to Remove DOAC from Patients’ Plasma. Potential Usefulness for Routine Coagulation and Thrombophilia Testing in DOAC Treated Patients
-
Abstract Number: LPB0053
Activated FVIII Inactivation Occurs Outside of the Intrinsic Xase Complex
-
Abstract Number: LPB0087
Activated Platelets Transfer miR-223 into Endothelial Cells via Microparticles to Downregulate ICAM-1 Expression among Septic Conditions
-
Abstract Number: LPB0007
Activated Protein C (APC) Resistance in FV-W1920R (FV-NARA) Was Caused by the Defective Association between FV-W1920R and Protein S (PS) in the APC/PS/FVa Assembly
-
Abstract Number: PB0731
Activated Protein C Impacts Survival and Activity of Mast Cells and Neurons via the Modulation of Nuclear Factor-κB Activation
-
Abstract Number: LPB0017
Activation Mechanism Dependent Surface Exposure of Cellular FXIII on Platelets and Platelet Microparticles: Immunofluorescence and Immune Electron Microscopic Study
-
Abstract Number: LPB0090
Active Cancer and Venous Thromboembolism: Safety and Effectiveness of Edoxaban in Patients from the Noninterventional Global ETNA-VTE Program
-
Abstract Number: OC 11.3
Active Sorting of Platelets and Red Blood Cells in Contracting Blood Clots is Driven by Platelet-generated Forces that Stiffen Fibrin
-
Abstract Number: LPB0031
Activity and Cleavage of von Willebrand Disease Type 2B Variants
-
Abstract Number: PB0299
Acute Liver Necrosis in a Sars-Cov-2 Positive Patient with Triple Positive Antiphospholipid Syndrome
-
Abstract Number: PB0493
Acute Myelogenous Leukemia in a Patient with Mild Haemophilia A. A Case Report at Hospital Infantil de México Federico Gómez
-
Abstract Number: PB0732
Acute Promyelocytic Leukaemia with Anti Phospholipid Antibody Syndrome – Double Trouble
-
Abstract Number: PB1198
Acute VTE in HIV versus Non-HIV population – Nationwide Analysis of Mortality, Morbidity, Demographics and Healthcare Utilization
-
Abstract Number: OC 43.4
ADAMTS-13/VWF Ratio as Biomarker for Portal Vein Thrombosis (PVT) Development in Cirrhotic Patients: A Prospective Study
-
Abstract Number: PB0088
Adaptation of fixed prothrombin complex concentrate dosing for vitamin K antagonist-related bleeding in the Netherlands
-
Abstract Number: PB1154
Additional Risk Factors of Hereditary Thrombophilia in the North-Western Region of Russia
-
Abstract Number: PB0574
Adherence to Prophylaxis and Recording of Home-treatment Following a Switch to Extended Half-life Clotting Factor Concentrate
-
Abstract Number: PB0168
Adjusting D-dimer to Lung Disease Extent to Exclude Pulmonary Embolism in COVID-19 Patients (Co-LEAD)
-
Abstract Number: PB0675
Administration of fVIII Protein through Human Placental Cells Reduces the Risk of an Antibody Response in Juvenile Sheep
-
Abstract Number: PB0530
Adoption of Emicizumab for Hemophilia A in Europe: Data from the 2020 European Association for Haemophilia and Allied Disorders Survey
-
Abstract Number: LPB0008
ADP-induced Platelet-associated Tissue Factor Expression: Unique Involvement of the P2Y12 Receptor and Modulation by Clopidogrel Treatment
-
Abstract Number: OC 37.3
Affimers Modulate GPVI Interactions with Collagen/Fibrinogen and GPVI-mediated Platelet Aggregation
-
Abstract Number: PB0270
After the Storm; 6-month Follow up Outcomes and Management of COVID-19 Related Venous Thromboembolism
-
Abstract Number: PB0909
Age-specific Changes in von Willebrand Factor Multimers in Healthy Children and Adults
-
Abstract Number: PB0907
Agglomeration and then Capture within 10 ms Creates Shear-induced Platelet Aggregation Controlled by von Willebrand Factor Concentration
-
Abstract Number: PB1179
Agreement between Physician and Nurse Derived Wells Score as Part of the Assessment of Deep Vein Thrombosis in a Rapid Access Ambulatory Clinic
-
Abstract Number: OC 33.2
AI_PREMie: A Novel Risk Stratification Tool for Preeclamptic-toxaemia
-
Abstract Number: PB0623
AKATSUKI Study: A Prospective, Multicenter, Phase IV Study to Evaluate the Safety of Emicizumab Under and Immediately After Immune Tolerance Induction (ITI) Therapy in Persons with Congenital Hemophilia A (PwHA) with Factor (F) VIII Inhibitors
-
Abstract Number: LPB0092
Alteration of the Circulating Plasma Proteome by FXa Inhibition in Venous Thromboembolism and the Relationship with Clinical Outcome
-
Abstract Number: PO129
Alterations of the Coagulation Profile in Peruvians Admitted for Pneumonia due to SARS-COV2: Cross-sectional Study
-
Abstract Number: PB0082
Altered Hemostasis and Complement in Pediatric Patients Treated with Cardiopulmonary Bypass
-
Abstract Number: PB0820
Altered Hemostatic Potential in Adults with Primary ITP
-
Abstract Number: OC 15.2
Altered Platelet Proteome and Platelet-leukocyte Interactions in Patients with COVID-19
-
Abstract Number: PB0159
Altered Protein S Activity Contributes Significantly to COVID-19 Pro-thrombotic State
-
Abstract Number: OC 24.4
Altered vWF-FVIII Binding Modulates the Factor VIII Immune Response
-
Abstract Number: LPB0116
An Accurate and Simple Liquid Chromatography Tandem Mass-spectrometric Method for the Quantification of Emicizumab in People with Hemophilia A
-
Abstract Number: PB0737
An Assessment of Some Inflammatory and Haemostatic Proteins as Biomarkers for Vaso-occlusive Crises in Sickle Cell Anaemia Patients
-
Abstract Number: NUR 01.1
An Exploration of Venous Thromboembolism (VTE) Prophylaxis Administration Practices across a Hospital Network
-
Abstract Number: PO178
An Insilco Approach to Venous Thromboembolism (VTE) Using Network Based Medicine with Direct Oral Anticoagulants (DOACs)
-
Abstract Number: LPB0093
An Overall Evaluation of the Adjusted Version of Global Antiphospholipid Syndrome Score (aGAPSS) on Primary Obstetric Antiphospholipid Syndrome (POAPS) Patients
-
Abstract Number: PB0999
An Oxidative Stress-induced Platelet-associated Tissue Factor Expression Characterizes Patients with Migraine and Patent Foramen Ovale
-
Abstract Number: PB0300
Analysing Risk Factors for Thrombosis in Covid-19 and Cancer Patients
-
Abstract Number: PB0072
Analysis of Coagulation Factors in Fresh-frozen Plasma
-
Abstract Number: PO140
Analysis of Hospitalization Factors of Hemophilia: 12 Years of Experience in a Single Center
-
Abstract Number: PB0786
Analysis of Novel Risk Factors for Arterial or Venous Thrombosis in Neonates
-
Abstract Number: PO185
Analysis of Risk Factors for Hemorrhagic Complications of Anticoagulant Therapy
-
Abstract Number: PB0481
Analysis of the Percentage of Persons with Severe Hemophilia A as an Indicator of Care
-
Abstract Number: PB0385
Analytical Performance of the Novel Haema T4 Thromboelastograph
-
Abstract Number: PB0358
Analytical Performances of a New Immunoturbidimetric D-Dimer Assay
-
Abstract Number: PB0204
Anemia and Enhancement of Coagulation Are Associated during Severe COVID-19 Infection
-
Abstract Number: LPB0043
Annexin A2-mediated Surface Fibrinolysis Is Impaired in Non-alcoholic Steatohepatitis (NASH) Cirrhosis and May Contribute to Portal Vein Thrombosis
-
Abstract Number: PB1029
Annexin V Binding Detects Platelet Procoagulant Commitment but Is Not Sensitive to Reductions in the Level of Platelet PS Exposure
-
Abstract Number: PB1294
Antepartum Anemia and Risk of Postpartum Hemorrhage: A Comprehensive Review of the Literature
-
Abstract Number: PB0135
Anti TFPI for Hemostasis Induction in Patients with Rare Bleeding Disorders, an ex vivo Thrombin Generation (TG) Guided Study
-
Abstract Number: OC 53.4
Anti-ADAMTS13 Antibodies in Patients with Hereditary Thrombotic Thrombocytopenic Purpura (hTTP)
-
Abstract Number: PB0316
Anti-annexinv Serum Levels and Haematological Indices in Sickle Cell Anaemia Patients in Vasooclusive Crisis and Steady States Seen at Lagos University Teaching Hospital Lagos Nigeria
-
Abstract Number: PB0769
Anti-cancer Activity of Tempeh – Spermine Can Induce the Necrosis of HeLa Cells
-
Abstract Number: PB0280
Anti-coagulant Drugs among Moderate, Severe and Critically Ill COVID 19 Patients in the Second Referral Hospital in Surabaya
-
Abstract Number: OC 66.2
Anti-cysteine/Spacer Autoantibodies that Open the Conformation of ADAMTS13 Are a Common Feature of the Autoimmune Response in Immune-mediated Thrombotic Thrombocytopenic Purpura
-
Abstract Number: PB0184
Anti-factor Xa Activity after Intermediate Dose Nadroparin for Thrombosis Prophylaxis in Critically Ill COVID-19 Patients with and without Acute Kidney Injury
-
Abstract Number: PO162
Anti-lymphoma Therapy Improves Thrombocytopenia in a Young Patient with Hodgkin Lymphoma: A Case Report
-
Abstract Number: PB0748
Anti-platelet Drugs and Risk of Intracranial Hemorrhage in Patients with Metastatic Brain Tumors
-
Abstract Number: OC 70.2
Anti-thrombotics and Anti-hypertensives with Direct Action against SARS-CoV-2
-
Abstract Number: PB0262
Anticoagulant Response to Tailored Low Molecular Weight Heparin Regimens in Patients with COVID-19 Infection
-
Abstract Number: PB1118
Anticoagulant Therapy and Related Bleeding Complications in Internal Medicine Wards
-
Abstract Number: PB0370
Anticoagulated Patients Exhibit Intact Endogenous Thrombin Potential Using ST Genesia Unlike the Calibrated Automated Thrombogram
-
Abstract Number: PB0086
Anticoagulation and Antiplatelet Management during the Perioperative Period: A Daily Practice Cohort Prospective Study
-
Abstract Number: NUR 01.6
Anticoagulation Stewardship – Time To Formalize the Role?
-
Abstract Number: PB0202
Anticoagulation Strategies and Risk Of Bleeding Events in Critically ill COVID-19 Patients
-
Abstract Number: PB1244
Anticoagulation Strategies during Conditioning-induced Thrombocytopenia in Hematopoietic Cell Transplant Patients with Venous Thromboembolism
-
Abstract Number: PB0230
Anticoagulation with Tinzaparin in COVID-19 Patients in ICU: Are Low Anti-Xa Levels Associated with the Development of Thrombo-embolic Events?
-
Abstract Number: PB0728
Antigenic Levels of von Willebrand Factor Predict Complications and Mortality in Patients with Liver Cirrhosis
-
Abstract Number: PB0998
Antiplatelet Activity Produced by Chloroacilhidroquinones via Inhibition of the Mitochondrial Bioenergy
-
Abstract Number: PB0754
Antiplatelet and Cytostatic Properties of Nilotinib Synthetic Analogues
-
Abstract Number: PB1033
Antiplatelet Effect of Nobiletin Is Mediated by Activation of DP1 Receptor
-
Abstract Number: PB1246
Antithrombotic Management of Patients with Deep Vein Thrombosis and Venous Stents: An International Registry
-
Abstract Number: OC 60.2
Antithrombotic Potential of a Single-domain Antibody Enhancing the Anticoagulant Activity of Protein S
-
Abstract Number: PB1260
AntiXa Heparin Dosing Protocol Evaluation at a Large Academic Medical Center
-
Abstract Number: PB0622
AOZORA Study: Long-Term Safety and Joint Health in Pediatric Patients with Hemophilia A without FVIII Inhibitors Receiving Emicizumab – Protocol for a Multicenter, Open-label, Phase IV Clinical Study
-
Abstract Number: OC 71.2
Apolipoprotein A-IV Polymorphisms Q360H and T347S Reduce its Inhibitory Effect against Thrombosis
-
Abstract Number: PB0247
Apparent Different of Lupus Anticoagulant Disappearance in Novel Coronavirus 2019 Patients as a Distinct Clinical Feature
-
Abstract Number: PB0406
Application of the ISTH-BAT In Congenital Fibrinogen Disorders
-
Abstract Number: PB1075
Appropriate dose of Dabigatran in Asian Population
-
Abstract Number: PB1162
Appropriateness of Thrombophilia Evaluation and Anticoagulation Management: A Multi-specialty Survey of Practitioners at Tower Health Reading Hospital
-
Abstract Number: OC 33.4
Are Antiphospholipid Antibodies a Poor Prognostic Factor for HELLP Syndrome?
-
Abstract Number: PB0058
Are Direct Oral Anti-Xa Inhibitors Absorbed in Cancer Patients after Gastrectomy? A Case Series
-
Abstract Number: PB0173
Are Mild or Moderate COVID-19 Patients at Higher Risk of VTE? A Comparison of Two Prospective European Cohorts in Emergency Departments
-
Abstract Number: PB0853
Arginine-containing Peptides and Acetylsalicylic Acid: Evaluation of Antiplatelet Effects
-
Abstract Number: PB1054
Artificial Intelligence Classifies APS in Anticoagulated Patients Based on Thrombin Generation
-
Abstract Number: PB0249
Artificial Neural Networks to Predict Covid-19 Progression of Moderate Hospitalized Patients using Early Clinical Parameters and Blood Tests
-
Abstract Number: PB0890
Aspirin Resistance after Total Hip or Knee Arthroplasties
-
Abstract Number: LPB0072
Aspirin vs P2RY12-Inhibitors to Reduce Cancer Associated Thrombosis and Tumor Growth in Digestive Cancers
-
Abstract Number: OC 15.4
Assessing Complement Activation in COVID-19 Predicts Hypoxemia and Mortality
-
Abstract Number: OC 63.1
Assessing the Clinical Probability of Pulmonary Embolism during Pregnancy: The Pregnancy-Adapted Geneva (PAG) Score
-
Abstract Number: OC 72.3
Assessing the Pharmacodynamics of RUC-4 (Zalunfiban), a Novel αIIbβ3 Antagonist, Using VerifyNow Assays in Patients with ST-Segment Elevation Myocardial Infarction (STEMI) Treated with Aspirin and Ticagrelor
-
Abstract Number: PB1227
Assessing Use of Surrogate Outcome Measures in Randomized Controlled Trials Investigating Venous Thromboembolism Prophylaxis
-
Abstract Number: PB0421
Assessment of DOACs Effect on Clot Formation and Fibrinolysis Using the FibWave
-
Abstract Number: PB0384
Assessment of Low Response Rates to P2Y12 Inhibition in Cardiology Patients: Comparison of the VerifyNow P2Y12 and Anysis-P2Y12 Assay
-
Abstract Number: PB0349
Assessment of Sample Stability after Freezing on ST Genesia System Using the STG-BleedScreen Application
-
Abstract Number: PB0528
Assessment of the Bleeding Phenotype in Patients with Non-severe Hemophilia According to the ISTH Bleeding Assessment Tool (BAT)
-
Abstract Number: PB0989
Assessment of the Effects of Syk and BTK Inhibitors on GPVI-mediated Platelet Signaling and Function
-
Abstract Number: PB1309
Assessment of the Utility of the Pregnancy-adapted YEARS Algorithm in Predicting Presence of Pulmonary Embolism (PE) in Pregnant Women (PA-PE)
-
Abstract Number: PB0592
Assessment of Thrombin Generation on Severe Haemophilia A Patients in the Clinical Laboratory
-
Abstract Number: PB0417
Assessment of Сardiometabolic Biomarkers in Young Adults with Normal Body Weight and Obesity
-
Abstract Number: PB0868
Assigning Pathogenicity to a Novel de Novo ACTN1 Variant in a Child with Macrothrombocytopenia: A Case Description And Review of Previously Identified Variants
-
Abstract Number: PO125
Associated Factors of Adherence to the Use of Coumarin Derivatives or Direct Oral Anticoagulants: Protocol of a Systematic Review
-
Abstract Number: PB1101
Association between Cancer and Anatomical Site of Venous Thromboembolic Disease
-
Abstract Number: PB1193
Association between Cardiovascular Risk Factors and Venous Thrombosis in the Elderly
-
Abstract Number: PB0476
Association between Factor VIII Deficiency and Low Bone Mineral Density in Children with Hemophilia
-
Abstract Number: PO127
Association between FGB – 455 G/A and PAI-1 – 675 5G / 4G Gene Polymorphisms and Covid-19 Severity
-
Abstract Number: LPB0142
Association between Non-O Blood Group and the Risk of Venous Thromboembolism due to Oral Contraceptive Therapy
-
Abstract Number: LPB0048
Association between Plaque Vulnerability and Neutrophil Extracellular Traps (NETs) Levels: The Plaque at RISK Study
-
Abstract Number: PB0271
Association between Race and the Incidence of Thrombosis in Hospitalized COVID-19 Patients Across a New York City Hospital System
-
Abstract Number: PB1240
Association of Adding Antiplatelet Therapy to Warfarin for Management of Venous Thromboembolism with Bleeding and Other Adverse Events
-
Abstract Number: OC 06.4
Association of Anticoagulation Resumption and Repeat Imaging on Venous Thromboembolism Recurrence after Allogeneic Hematopoietic Cell Transplantation (HCT)
-
Abstract Number: PO189
Association of Complete Blood Parameters, D-dimer and Lupus Anticoagulant with VTE Risk Score in Hospitalized Patients
-
Abstract Number: PB0256
Association of Elevated D-dimers with Severity and Outcome of Covid-19 Infection in Children
-
Abstract Number: LPB0139
Association of FXI Activity with Thrombo-inflammation, Extracellular Matrix Interactions, Lipid Metabolism and Apoptosis in Venous Thromboembolism
-
Abstract Number: OC 13.3
Association of Genetic Alterations with Severity of Disease in Type III vWD Patients
-
Abstract Number: PB0616
Association of Individual Pharmacokinetics-guided Regimen in Hemophilia A Patients and FVIII Consumption: A Single-center Study
-
Abstract Number: PB1098
Association of KRAS Mutation with Arterial Thromboembolism in Advanced Lung and Gastrointestinal Cancer
-
Abstract Number: PB0512
Association of Physical Activity with Bleeding Frequency in Children with Hemophilia A: A CHESS PAEDs Study Analysis
-
Abstract Number: PB0753
Association of Platelet Count and Coagulopathy before, during and Post Chemotherapy: Is it Worth Doing?
-
Abstract Number: PB1069
Association of Retest Interval with INR Control in Warfarin Patients with Markedly Out of Range INRs
-
Abstract Number: OC 76.2
Association of Single Nucleotide Polymorphisms with Major Bleeding Risk during Vitamin K Antagonists Treatment: A Case-cohort Study
-
Abstract Number: PB0144
Association of the Angiopoietin/Tie2 and VEGF-A Pathways with clinical and Laboratory Markers of Disease Severity in COVID-19
-
Abstract Number: OC 64.3
Associations of Residual Venous Obstruction, d-Dimers, fFctor VIII and CRP with Long-term Outcomes of Deep Vein Thrombosis
-
Abstract Number: PB0193
Atherothrombotic Events in Hospitalized COVID-19 Patients Are Associated with Diabetes mellitus
-
Abstract Number: PB0107
Atrial Flutter and Intracardiac Thrombus After Cardiac Surgery
-
Abstract Number: PB0943
Atypical Presentation of VWD Leading to Discovery of Novel VWF Mutation
-
Abstract Number: PB0828
Autoimmune Platelet Function Disorders: Systematic Review of Acquired Glanzmann Thrombasthenia and Acquired Delta Storage Pool Disease Cases
-
Abstract Number: PB1064
Automated Methods for the Enhancement of Lupus Anticoagulant Mixing Study Sensitivities
ISTH 2021 Congress
July 17-21, 2021. Philadelphia, PA.